DNA hypermethylation markers of poor outcome in laryngeal cancer

Clinical Epigenetics

Volumn 1, Issue 1-2, 2010, Pages 61-69

  Stephen, Josena K ^a   Chen, Kang Mei ^a   Shah, Veena ^a   Havard, Shaleta ^a   Kapke, Alissa ^a   Lu, Mei ^a   Benninger, Michael S ^b   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ESR1; HIC1; Hypermethylation; Laryngeal cancer

Indexed keywords

APC PROTEIN; BIOLOGICAL MARKER; BRCA2 PROTEIN; CADHERIN; CADHERIN 13; CELL ADHESION MOLECULE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; DNA; ESTROGEN RECEPTOR ALPHA; GLUTATHIONE TRANSFERASE P1; LIGASE; PROTEIN CHFR; PROTEIN IGSF4; PROTEIN MLH1; PROTEIN P73; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DELAYED DIAGNOSIS; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNGEAL BIOPSY; LARYNX CARCINOMA; MALE; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS; TUMOR VASCULARIZATION;

EID: 79952361977     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-010-0005-3     Document Type: Article

References (65)

1. Arzimanoglou II, Hansen LL, Chong D, Li Z, Psaroudi MC, Dimitrakakis C, Jacovina AT, Shevchuk M, Reid L, Hajjar KA, Vassilaros S, Michalas S, Gilbert F, Chervenak FA, Barber HR (2002) Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Res 22(2A):969-975 (Pubitemid 34475258)
2. Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet 16(4):168-174 (Pubitemid 30169152)
3. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72:141-196 (Pubitemid 27435555)
4. Cairns P (2004) Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann N Y Acad Sci 1022:40-43 (Pubitemid 38951579)
5. Cameron EE, Bachman KE, Myöhänen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21(1):103-107 (Pubitemid 29036293)
6. Chan MF, Liang G, Jones PA (2000) Relationship between transcription and DNA methylation. Curr Top Microbiol Immunol 249:75-86 (Pubitemid 30133494)
7. Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M, Karp JE, Gokgoz N, Wunder JS, Andrulis IL, Levine AJ, Mankowski JL, Baylin SB (2004) Epigenetic and genetic loss of hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6(4):387-398 (Pubitemid 39361439)
8. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB (2005) Tumor suppressor hic1 directly regulates sirt1 to modulate p53- dependent DNA-damage responses. Cell 123(3):437-448 (Pubitemid 41546674)
9. Chen K, Sawhney R,KhanM, BenningerMS,Hou Z, Sethi S, Stephen JK, WorshamMJ (2007) Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 133(11):1131-1138 (Pubitemid 350157026)
10. Clayman GL, Lippman SM, Laramore GF et al (2000) Neoplasms of the head and neck. Cancer medicine, 5th edn. BC Becker Inc, New York (section 27)
11. Costello JF, Plass C (2001) Methylation matters. J Med Genet 38 (5):285-303 (Pubitemid 32433981)
12. Dong SM, Kim HS, Rha SH, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7(7):1982-1986 (Pubitemid 32994835)
13. Dong S, Pang JC, Hu J, Zhou LF, Ng HK (2002) Transcriptional inactivation of tp73 expression in oligodendroglial tumors. Int J Cancer 98(3):370-375 (Pubitemid 34188680)
14. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 (6990):457-463 (Pubitemid 38715140)
15. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59(1):67-70 (Pubitemid 29062958)
16. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61 (8):3225-3229 (Pubitemid 32695003)
17. Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Zabarovsky ER, Roy A, Roychoudhury S, Panda CK (2010) Frequent alterations of the candidate genes hmlh1, itga9 and rbsp3 in early dysplastic lesions of head and neck: Clinical and prognostic significance. Cancer Sci 101(6):1511-1520
18. Haigis MC, Guarente LP (2006) Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20:2913-2921 (Pubitemid 44771725)
19. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA (1984) Regression modelling strategies for improved prognostic prediction. Stat Med 3(2):143-152 (Pubitemid 14052973)
20. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabianova E, Rudnai P, Brennan P (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165(7):814-820 (Pubitemid 46434604)
21. Hirohashi S (1998) Inactivation of the e-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153(2):333-339 (Pubitemid 28373643)
22. HornerMJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (2009) Seer cancer statistics review, 1975-2006. National Cancer Institute, Bethesda
23. Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP (2003) Epigenetic inactivation of tslc1 gene in nasopharyngeal carcinoma. Mol Carcinog 38(4):170-178 (Pubitemid 37523709)
24. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor cpg island links ageing and neoplasia in human colon. Nat Genet 7(4):536-540 (Pubitemid 24308343)
25. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA (2001) Accelerated age-related cpg island methylation in ulcerative colitis. Cancer Res 61:3573-3577 (Pubitemid 32694963)
26. Ito T, Shimada Y, Hashimoto Y, Kaganoi J, Kan T, Watanabe G, Murakami Y, Imamura M (2003) Involvement of tslc1 in progression of esophageal squamous cell carcinoma. Cancer Res 63(19):6320-6326 (Pubitemid 37255179)
27. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3(6):415-428 (Pubitemid 34587077)
28. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21(2):163-167 (Pubitemid 29070360)
29. Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH (2004) Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 22(12):2363-2370 (Pubitemid 41115393)
30. Kuhnt T, Mueller AC, Pelz T, Haensgen G, Bloching M, Koesling S, Schubert J, Dunst J (2005) Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy. J Cancer Res Clin Oncol 131 (11):758-764 (Pubitemid 41577953)
31. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, Murakami Y (2001) Tslc1 is a tumor- suppressor gene in human non-small-cell lung cancer. Nat Genet 27(4):427-430 (Pubitemid 32268425)
32. Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M (1996) Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 106(9 Pt 1):1157-1166 (Pubitemid 26304609)
33. Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ, To KF (2002) Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8(6):1761-1766 (Pubitemid 34633732)
34. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69 (6):915-926
35. Li E, Beard C, Jaenisch R (1993) Role for DNA methylation in genomic imprinting. Nature 366(6453):362-365 (Pubitemid 23349366)
36. Li LC, Chui R, Nakajima K, Oh BR, Au HC, Dahiya R (2000) Frequent methylation of estrogen receptor in prostate cancer: Correlation with tumor progression. Cancer Res 60:702-706 (Pubitemid 30094570)
37. Malekzadeh K, Sobti RC, Nikbakht M, Shekari M, Hosseini SA, Tamandani DK, Singh SK (2009) Methylation patterns of rb1 and casp-8 promoters and their impact on their expression in bladder cancer. Cancer Invest 27(1):70-80
38. Moscow JA, Townsend AJ, Goldsmith ME, Whang-Peng J, Vickers PJ, Poisson R, Legault-Poisson S, Myers CE, Cowan KH (1988) Isolation of the human anionic glutathione s-transferase cdna and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci U S A 85(17):6518-6522
39. Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ (1995) Cdkn2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16ink4 protein induction by 5-aza 2'deoxycytidine. Oncogene 11(6):1211-1216
40. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94(2):153-156 (Pubitemid 32911406)
41. Pegg AE (1990) Mammalian o6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50(19):6119-6129 (Pubitemid 20323662)
42. Pfeifer GP, Tanguay RL, Steigerwald SD, Riggs AD (1990) In vivo footprint and methylation analysis by pcr-aided genomic sequencing: Comparison of active and inactive x chromosomal DNA at the cpg island and promoter of human pgk-1. Genes Dev 4(8):1277-1287
43. Ponglikitmongkol M, Green S, Chambon P (1988) Genomic organization of the human oestrogen receptor gene. EMBO J 7 (11):3385-3388
44. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, SussmanMS, Ouyang P, Milliken EE, Issa JP (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43:985-991 (Pubitemid 29413198)
45. Rathi A, Virmani AK, Harada K, Timmons CF, Miyajima K, Hay RJ, Mastrangelo D, Maitra A, Tomlinson GE, Gazdar AF (2003) Aberrant methylation of the hic1 promoter is a frequent event in specific pediatric neoplasms. Clin Cancer Res 9(10 Pt 1):3674-3678 (Pubitemid 37169234)
46. Robertson KD (2001) DNA methylation, methyltransferases, and cancer. Oncogene 20:3139-3155 (Pubitemid 32553570)
47. Robertson KD, Wolffe AP (2000) DNA methylation in health and disease. Nat Rev Genet 1(1):11-19
48. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G, Molina FJ, Calasanz MJ, Prosper F, Heiniger A, Torres A (2004) Promoter hypermethylation of cancer-related genes: A strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104(8):2492-2498 (Pubitemid 39331852)
49. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60(4):892-895 (Pubitemid 30129522)
50. Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, Suzuki H, Yawata A, Kusano M, Fujita M, Hosokawa M, Yanagihara K, Tokino T, Imai K (2002) DNA methylation and histone deacetylation associated with silencing dap kinase gene expression in colorectal and gastric cancers. Br J Cancer 86(11):1817-1823 (Pubitemid 34712929)
51. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30(12):e57
52. Sethi S, LuM, Kapke A, BenningerMS,WorshamMJ (2009) Patient and tumor factors at diagnosis in a multi-ethnic primary head and neck squamous cell carcinoma cohort. J Surg Oncol 99(2):104-108
53. Sherr CJ (1996) Cancer cell cycles. Sciences 274:1672-1677
54. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T (2001) Inactivation of the p14(arf), p15(ink4b) and p16(ink4a) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 37(6):498-504 (Pubitemid 32588775)
55. Stephen JK, Vaught LE, Chen KM, Shah V, Schweitzer VG, Gardner G, Benninger MS, Worsham MJ (2007) An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 133(7):684-692 (Pubitemid 47080421)
56. Suzuki M, Suzuki T, Asai M, Ichimura K, Nibu K, Sugasawa M, Kaga K (2007) Clinicopathological factors related to cervical lymph node metastasis in a patient with carcinoma of the oral floor. Acta Otolaryngol Suppl 559:129-135 (Pubitemid 351380342)
57. Takai D, Jones PA (2002) Comprehensive analysis of cpg islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 99 (6):3740-3745 (Pubitemid 34252176)
58. Tseng R, Lee C, Hsu H, Tzao C, Wang Y (2009) Distinct hic1-sirt1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. Neoplasia 11(8):763-770
59. Uesugi H, Uzawa K, Kawasaki K, Shimada K, Moriya T, Tada A, Shiiba M, Tanzawa H (2005) Status of reduced expression and hypermethylation of the apc tumor suppressor gene in human oral squamous cell carcinoma. Int J Mol Med 15(4):597-602
60. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB (1995) P53 activates expression of hic-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1 (6):570-577
61. Ward E, HalpernM, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A (2008) Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58(1):9-31
62. Worsham MJ, Pals G, Schouten JP, Van Spaendonk RM, Concus A, Carey TE, Benninger MS (2003) Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129(7):702-708 (Pubitemid 36858953)
63. WorshamMJ, Chen KM, Meduri V, Nygren AO, Errami A, Schouten JP, Benninger MS (2006) Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132(6):668-677 (Pubitemid 43927046)
64. Yokoyama J, Shiga K, Sasano H, Suzuki M, Takasaka T (1996) Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers. Anticancer Res 16:641-644 (Pubitemid 26181992)
65. Zou CP, Youssef EM, Zou CC, Carey TE, Lotan R (2001) Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor rar beta and on retinoid resistance in human squamous carcinoma cells. Oncogene 20(47):6820-6827 (Pubitemid 33052172)